Your browser doesn't support javascript.
loading
Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial.
Bernal-Estévez, David A; Ortíz Barbosa, Mauren A; Ortíz-Montero, Paola; Cifuentes, Claudia; Sánchez, Ramiro; Parra-López, Carlos A.
Affiliation
  • Bernal-Estévez DA; Immunology and Clinical Oncology Research Group, Fundación Salud de los Andes, Bogotá, Colombia.
  • Ortíz Barbosa MA; Immunology and Clinical Oncology Research Group, Fundación Salud de los Andes, Bogotá, Colombia.
  • Ortíz-Montero P; Immunology and Clinical Oncology Research Group, Fundación Salud de los Andes, Bogotá, Colombia.
  • Cifuentes C; Oncology Department, Hospital Universitario Mayor de Méderi, Bogotá, Colombia.
  • Sánchez R; Immunology and Translational Medicine Research Group, Department of Microbiology, Medical School, Universidad Nacional de Colombia, Bogotá, Colombia.
  • Parra-López CA; Immunology and Translational Medicine Research Group, Department of Microbiology, Medical School, Universidad Nacional de Colombia, Bogotá, Colombia.
Front Immunol ; 12: 669965, 2021.
Article in En | MEDLINE | ID: mdl-34489928
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Breast Neoplasms / T-Lymphocytes / Antineoplastic Combined Chemotherapy Protocols / Immunotherapy, Adoptive / Lymphocytes, Tumor-Infiltrating / Cancer Vaccines / Neoadjuvant Therapy Type of study: Clinical_trials / Guideline Limits: Female / Humans / Middle aged Country/Region as subject: America do sul / Colombia Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Breast Neoplasms / T-Lymphocytes / Antineoplastic Combined Chemotherapy Protocols / Immunotherapy, Adoptive / Lymphocytes, Tumor-Infiltrating / Cancer Vaccines / Neoadjuvant Therapy Type of study: Clinical_trials / Guideline Limits: Female / Humans / Middle aged Country/Region as subject: America do sul / Colombia Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: Country of publication: